Klaus Kaczirek

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

Birgit Gruenberger, Johannes Schueller, Ute Heubrandtner et al. · The Lancet Oncology · 2010 · 243 citations

Gastrointestinal Oncology, Medicine, Biliary Cancer +7

Association of <i>BRAF</i> Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

Georgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos et al. · JAMA Surgery · 2018 · 199 citations · Full text

Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.

C. Passler, Christian Scheuba, Gerhard Prager et al. · Endocrine Related Cancer · 2004 · 153 citations · Full text

Prognostic Factors, Ftc Patients, Medicine +11

Sinusoidal Obstruction Syndrome Impairs Long-Term Outcome of Colorectal Liver Metastases Treated with Resection after Neoadjuvant Chemotherapy

Dietmar Tamandl, Markus Klinger, Sandra Eipeldauer et al. · Annals of Surgical Oncology · 2010 · 133 citations

Surgical Oncology, Hepatology, Neoadjuvant Chemotherapy +12

A “defined baseline” in PTH monitoring increases surgical success in patients with multiple gland disease

Philipp Riss, Klaus Kaczirek, George Heinz et al. · Surgery · 2007 · 114 citations

Urology, Endocrine Disease, Surgical Pathology +10